Literature DB >> 30159622

Correlation of native T1 mapping with right ventricular function and pulmonary haemodynamics in patients with chronic thromboembolic pulmonary hypertension before and after balloon pulmonary angioplasty.

F C Roller1, S Kriechbaum2,3, A Breithecker4, C Liebetrau2,3,5, M Haas2,3, C Schneider4, A Rolf2,3,5, S Guth6, E Mayer6, C Hamm2,3,5, G A Krombach4, C B Wiedenroth6.   

Abstract

OBJECTIVES: The aim of this study was to assess native T1 mapping in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) before and 6 months after balloon pulmonary angioplasty (BPA) and compare the results with right heart function and pulmonary haemodynamics.
METHODS: Magnetic resonance imaging at 1.5 T and right heart catheterisation were performed in 21 consecutive inoperable CTEPH patients before and 6 months after BPA. T1 values were measured within the septal myocardium, the upper and lower right ventricular insertion points, and the lateral wall at the basal short-axis section. In addition, the area-adjusted septal native T1 time (AA-T1) was calculated and compared with right ventricular function (RVEF), mean pulmonary arterial pressure (mPAP) and pulmonary vascular resistance (PVR).
RESULTS: The mean AA-T1 value decreased significantly after BPA (1,045.8 ± 44.3 ms to 1,012.5 ± 50.4 ms; p < 0.001). Before BPA, native T1 values showed a moderate negative correlation with RVEF (r = -0.61; p = 0.0036) and moderate positive correlations with mPAP (r = 0.59; p < 0.01) and PVR (r = 0.53; p < 0.05); after BPA correlation trends were present (r = -0.21, r = 0.30 and r = 0.35, respectively).
CONCLUSIONS: Native T1 values in patients with inoperable CTEPH were significantly lower after BPA and showed significant correlations with RVEF and pulmonary haemodynamics before BPA. Native T1 mapping seems to be indicative of reverse myocardial tissue remodelling after BPA and might therefore have good potential for pre-procedural patient selection, non-invasive therapy monitoring and establishing a prognosis. KEY POINTS: • BPA is a promising treatment option for patients with inoperable CTEPH • Native septal T1 values significantly decrease after BPA and show good correlations with right ventricular function and haemodynamics before BPA • Prognosis and non-invasive therapy monitoring might be supported in the future by native T1 mapping.

Entities:  

Keywords:  Angioplasty; Magnetic resonance imaging; Pulmonary embolism; Pulmonary hypertension

Mesh:

Year:  2018        PMID: 30159622     DOI: 10.1007/s00330-018-5702-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  46 in total

1.  Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.

Authors:  Ravi G Assomull; Sanjay K Prasad; Jonathan Lyne; Gillian Smith; Elizabeth D Burman; Mohammed Khan; Mary N Sheppard; Philip A Poole-Wilson; Dudley J Pennell
Journal:  J Am Coll Cardiol       Date:  2006-10-31       Impact factor: 24.094

2.  Delayed contrast-enhanced magnetic resonance imaging in pulmonary arterial hypertension.

Authors:  Gerry P McCann; Aernout M Beek; Anton Vonk-Noordegraaf; Albert C van Rossum
Journal:  Circulation       Date:  2005-10-18       Impact factor: 29.690

3.  Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

Authors:  Serge A van Wolferen; Johannes T Marcus; Anco Boonstra; Koen M J Marques; Jean G F Bronzwaer; Marieke D Spreeuwenberg; Pieter E Postmus; Anton Vonk-Noordegraaf
Journal:  Eur Heart J       Date:  2007-01-22       Impact factor: 29.983

4.  Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension.

Authors:  Javier Sanz; Santo Dellegrottaglie; Mbabazi Kariisa; Roxana Sulica; Michael Poon; Thomas P O'Donnell; Davendra Mehta; Valentin Fuster; Sanjay Rajagopalan
Journal:  Am J Cardiol       Date:  2007-06-27       Impact factor: 2.778

Review 5.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

6.  Prognostic factors in medically treated patients with chronic pulmonary embolism.

Authors:  J Lewczuk; P Piszko; J Jagas; A Porada; S Wójciak; B Sobkowicz; K Wrabec
Journal:  Chest       Date:  2001-03       Impact factor: 9.410

7.  Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism.

Authors:  Cecilia Becattini; Giancarlo Agnelli; Raffaele Pesavento; Mauro Silingardi; Renzo Poggio; Maria Rita Taliani; Walter Ageno
Journal:  Chest       Date:  2006-07       Impact factor: 9.410

8.  The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  James C C Moon; Emma Reed; Mary N Sheppard; Andrew G Elkington; Siew Yen Ho; Margaret Burke; Mario Petrou; Dudley J Pennell
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

9.  Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques.

Authors:  Karl-Friedrich Jakob Kreitner; Sebastian Ley; Hans-Ulrich Kauczor; Eckhard Mayer; Thorsten Kramm; Michael Bernhard Pitton; Frank Krummenauer; Manfred Thelen
Journal:  Radiology       Date:  2004-06-23       Impact factor: 11.105

10.  Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

Authors:  Vittorio Pengo; Anthonie W A Lensing; Martin H Prins; Antonio Marchiori; Bruce L Davidson; Francesca Tiozzo; Paolo Albanese; Alessandra Biasiolo; Cinzia Pegoraro; Sabino Iliceto; Paolo Prandoni
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

View more
  6 in total

Review 1.  Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart.

Authors:  Fawaz Alenezi; Taylor A Covington; Monica Mukherjee; Stephen C Mathai; Paul B Yu; Sudarshan Rajagopal
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

Review 2.  Cardiac Magnetic Resonance in Pulmonary Hypertension-an Update.

Authors:  Samer Alabed; Pankaj Garg; Christopher S Johns; Faisal Alandejani; Yousef Shahin; Krit Dwivedi; Hamza Zafar; James M Wild; David G Kiely; Andrew J Swift
Journal:  Curr Cardiovasc Imaging Rep       Date:  2020-11-07

3.  Association between myocardial fibrosis, as assessed with cardiac magnetic resonance T1 mapping, and persistent dyspnea after pulmonary embolism.

Authors:  Jostein Gleditsch; Øyvind Jervan; Mazdak Tavoly; Oliver Geier; René Holst; Frederikus A Klok; Waleed Ghanima; Einar Hopp
Journal:  Int J Cardiol Heart Vasc       Date:  2021-12-28

4.  Prognostic value of right ventricular native T1 mapping in pulmonary arterial hypertension.

Authors:  Ryotaro Asano; Takeshi Ogo; Yoshiaki Morita; Akiyuki Kotoku; Tatsuo Aoki; Kyoko Hirakawa; Sayuri Nakayama; Jin Ueda; Akihiro Tsuji; Mark T Waddingham; Yasutoshi Ohta; Tetsuya Fukuda; Keiko Ohta-Ogo; Hatsue Ishibashi-Ueda; Teruo Noguchi; Satoshi Yasuda
Journal:  PLoS One       Date:  2021-11-29       Impact factor: 3.240

5.  Noninvasive prediction of pulmonary hemodynamics in chronic thromboembolic pulmonary hypertension by electrocardiogram-gated computed tomography.

Authors:  Fritz C Roller; Selcuk M Yildiz; Steffen D Kriechbaum; Sebastian Harth; Andreas Breithecker; Christoph Liebetrau; Armin Schüßler; Eckhard Mayer; Christian W Hamm; Stefan Guth; Gabriele A Krombach; Christoph B Wiedenroth
Journal:  Eur J Radiol Open       Date:  2021-10-18

6.  MR 4D flow-based mean pulmonary arterial pressure tracking in pulmonary hypertension.

Authors:  Ursula Reiter; Gabor Kovacs; Clemens Reiter; Corina Kräuter; Volha Nizhnikava; Michael Fuchsjäger; Horst Olschewski; Gert Reiter
Journal:  Eur Radiol       Date:  2020-09-24       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.